Image
Akcea and Ionis Announce Approval of TEGSEDI™ (inotersen injection) in Canada
First and only treatment of its kind for Canadians with Hereditary Transthyretin-mediated Amyloidosis (hATTR amyloidosis) with Polyneuropathy – a rare and inherited disease.
- 05.10.2018, 14:39
- Kategoria: Zdrowie i styl życia
- Źródło: GlobeNewswire